Peter Akpunonu, MD, FACMT

Dr. Peter Akpunonu earned his medical degree from the University of Toledo College of Medicine and completed his Emergency Medicine residency at the University of Kansas Hospital. He went on to complete a fellowship in Medical Toxicology at Oregon Health and Science University in Portland, Oregon. Currently, he is an associate professor of Emergency Medicine at the University of Kentucky and is the medical director of the KY Poison Control Center. He is the medical director for Toxicology and Hyperbarics at the University of Kentucky. He is also the site director for the Radiation Injury Treatment Network. In addition to his teaching and clinical responsibilities, he is interested in medical toxicology and further research opportunities to explore opioid use treatment options.

Musa Alfaifi, MD, FACMT

Dr. Musa Suliman Alfaifi is a leading figure in both emergency medicine and medical toxicology in Saudi Arabia. He currently holds the position of program director for the Saudi Board of Emergency Medicine in the Armed Forces Hospital Southern Region (AFHSR). His credentials include an MD from King Khalid University, followed by residency training in emergency medicine from National Guard Hospital, Riyadh, and a fellowship in medical toxicology from Emory University.

Dr. Alfaifi’s dedication extends beyond clinical practice. He is a pioneer in emergency medicine education, having established the first Saudi Board of Emergency Medicine in the southern region and the leader of the medical toxicology fellowship foundation group in Saudi Arabia and co-founder of the arab board of Medical Toxicology program. He is actively involved in research, with a diploma in clinical research from Harvard and numerous publications on snakebite envenomation, toxicology, and emergency medicine. His expertise is further recognized through his role as a peer reviewer in the toxicology communication journal and his authorship of the chapter on snakebite in the MENA region for a relevant medical textbook.

Nicklaus Bradehoff, MD, FACMT

Dr. Nicklaus Brandehoff is board-certified in emergency medicine, medical toxicology, and addiction medicine with a passion for herpetology and a specialization in the research and treatment of envenomations.  He received his Doctorate of Medicine from the University of California San Francisco, completed residency in Emergency Medicine at UCSF-Fresno, and subsequently went on to complete a Medical Toxicology Fellowship at the Rocky Mountain Poison and Drug Center. 

Dr. Brandehoff practices emergency medicine and medical toxicology in both Colorado and California. He has an appointment as Assistant Clinical Professor of Emergency Medicine at the University of Colorado School of Medicine, is faculty at the Rocky Mountain Poison and Drug Center and Denver Health. He is also the executive director of the Asclepius Snakebite Foundation, a 501(c)3 non-profit, that focuses on improving snakebite education and management in West Africa. He has won numerous awards as an educator and published multiple articles and book chapters on the subject of envenomations.

Neeraj Chhabra, MD, MSCR, FACMT

Neeraj Chhabra, MD, MSCR is an Assistant Professor of Emergency Medicine at the University of Illinois Chicago with an appointment in the AI.Health4All Center for Health Equity using Machine Learning and Artificial Intelligence. He is a consulting physician for the Illinois Poison Center, Toxikon Consortium faculty, and a volunteer physician with Cook County Health. He completed his residency in Emergency Medicine at Cook County Health and fellowship in Medical Toxicology at the Toxikon Consortium. He actively practices both Medical Toxicology and Emergency Medicine. He is an NIH-funded researcher in substance use disorders and data science.

Tharwat El Zahran, MD, FACMT

Dr. El Zahran holds the position of Assistant Professor of Clinical Emergency Medicine and medical toxicologist at the American University of Beirut Medical Center (AUBMC). She obtained her medical doctor degree from the American University of Beirut in 2011 and completed her residency in emergency medicine at AUBMC. Subsequently, she underwent a comprehensive two-year medical toxicology fellowship at Emory University and the Centers for Disease Control and Prevention (CDC). Since August 2018, she has been a full-time faculty member at AUBMC, where she serves as the Medical Director for the emergency department and Co-director of the Toxicology Service within the Department of Emergency Medicine. Additionally, she holds an adjunct assistant professor position within the Department of Medical Toxicology at Emory University in Atlanta, Georgia, USA.

Dr. Zahran is actively engaged in research endeavors, boasting over 30 peer-reviewed publications. Notably, one of her significant research studies examines tianeptine exposures reported to the national poison data system across the United States, published in MMWR. She also contributed during her second-year fellowship at CDC, along her colleagues to an outbreak investigation in Illinois, related to synthetic cannabinoid and vitamin K antagonist brodifacoum, resulting in a co authored publication in MMWR titled “Notes from the Field: Outbreak of Severe Illness Linked to the Vitamin K Antagonist Brodifacoum and Use of Synthetic Cannabinoids – Illinois”. Her diverse research interests and publications encompass studies on lead exposure in children, snake bites in Lebanon, injuries from riot control agents, pufferfish poisoning, trazodone exposures, deanxit use disorder, household product toxicity, incidents related to chemical terrorism, synthetic cannabinoids, alfa-lipoic acid toxicity, and the establishment of toxicology services in resource-limited settings, including reports on adult and pediatric toxicological exposures. Currently, she is involved in a Randomized Controlled Double-Blind Non-Inferiority Trial to evaluate the efficacy of a novel antivenom in treating snake viper envenomations in Lebanon.

Paul Gee, MD, FACMT

Paul has been working as a Medical Toxicologist associated with the New Zealand National Poisons Centre since 2008. He received his basic Toxicology training with the University of Newcastle, Australia.  He is a Clinical Lecturer for the University of Otago Christchurch School of Medicine. He enjoys teaching and publishing research on pediatric poisoning, emerging drugs of abuse and trauma. He is a member of the Toxicology and Poisoning Network Australasia (TAPNA) and also a trustee for the Emergency Care Foundation (NZ).

Paul Gee is an Emergency Physician and Medical Toxicologist. He is a graduate of University of Auckland, New Zealand and completed his physician training for the Australasian College for Emergency Medicine at Christchurch Hospital, New Zealand,  where he works currently. He served as Director of Emergency Medicine (Resident) Training there for nine years. 

Matthew Griswold, MD, FACMT

Matthew Griswold is an assistant professor of Emergency Medicine at the University of Connecticut School of Medicine and the director of Medical Toxicology at Hartford Hospital. He received his medical doctorate from Boston University School of Medicine and completed his training in Emergency Medicine and Medical Toxicology at the University of Massachusetts. He is core faculty of the UCONN Integrated Residency on Emergency Medicine and also participates with the CT poison control center as a toxicology consultant. Dr. Griswold’s interests.

include medical education, as well as the emergence of novel psychoactive substances and overdose prevention. His research has focused on the identification of experiences of individuals who experience opioid overdose, novel strategies to ascertain fentanyl species among individuals with opioid use and identification of fentanyl analog adulterants. Dr. Griswold also leads medication education efforts in toxicology at the University of Connecticut School of Medicine.

Hallam Gugelmann, MD, FACMT

Hallam Gugelmann is a board-certified medical toxicologist and emergency medicine physician, currently working in biotech in Basel, Switzerland. Hallam completed his residency in emergency medicine at the Hospital of the University of Pennsylvania, where he served as chief resident his fourth year. This was followed by a fellowship in medical toxicology at UCSF. He subsequently worked as an emergency medicine attending at CPMC St Luke’s in San Francisco. During this time he served on and then joined the hospital’s ethics committee, and was a standing member of the pharmacy and therapeutics committee. He served as co-president of the San Francisco Emergency Physicians Association from 2018 to 2021, and was an associate director at the California Poison Control System’s San Francisco branch. In 2019, Hallam began using his toxicology training full-time at Genentech in drug development safety.

In 2021 he and his family moved to Switzerland, where he currently works as a senior medical director in a small biotechnology company in rare liver disease. His drug development experience includes rare diseases, neuroscience and psychiatry, oncology, and early- and late-phase drug development safety. Hallam is also a lecturing professor at the University of Basel in pharmacology and clinical toxicology, and provides medical-legal consultative services through the firm Park Dietz and Associates. In his free time he enjoys skiing, running, and swimming in the Rhein.

Ashley Haynes, MD, FACMT

Ashley Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addiction medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, a suboxone clinic, and performing bedside consults in addiction medicine and medical toxicology. She participates actively in the Addiction Toxicology Committee, as well as ACMT educational efforts.  She is currently planning an addiction medicine fellowship program and is a local stakeholder for opioid response activities. She has treated exactly one snakebite since leaving Texas but countless brown recluse envenomations. She lives in Wichita, KS with her husband and 3 children, and spends her free time painting and hiking.

Diane Hindman, MD, PharmD, FACMT

Dr. Hindman is a Board-Certified Pediatrician and Medical Toxicologist, and Registered Pharmacist. She is a Clinical Assistant Professor at the University of Arizona College of Medicine Phoenix and at the University of Arizona College of Pharmacy Tucson. She works as an Attending Physician in the Emergency Department (ED) at Phoenix Children’s in Phoenix AZ, and Medical Toxicologist at the University of Arizona Poison and Drug Information Center in Tucson AZ. She completed her medical degree at Trinity School of Medicine, pediatric residency at Rainbow Babies and Children’s Hospital, and medical toxicology fellowship at Emory University and the CDC. She received her pharmacy degrees from the University of Toronto and University of Colorado. She has also completed certification in clinical translational research at the University of Arizona College of Public Health, and will be starting an Addiction Medicine Fellowship in July 2024.

 Dr. Hindman wears many hats in addition to her role as an ED Attending. She serves on committees and has various other involvement with the American Academy of Pediatrics (AAP), American College of Medical Toxicology (ACMT), American Association for Emergency Psychiatry (AAEP), American Academy of Clinical Toxicology (AACT), and America’s Poison Centers (APC). She is also actively involved in numerous research and QI projects involving medication safety, appropriate prescribing, penicillin allergy delabeling, pediatric mental health disorders and boarding in the ED, and adolescent substance use. Dr. Hindman is also a provider and educator in AHLS, current Assistant Editor for the AHLS Provider Manual 6^th edition, and was involved in prior updates for the AHLS Radiological Incidents and Terrorism course. In these roles she is particularly interested in countermeasures for all categories of terrorism and emerging threats, and is currently working to establish a Radiation Injury Treatment Network (RITN) site at Phoenix Children’s in Arizona.

Rana Jaffer Hamed Hussein, MBBS, CABEM, MSc-Toxicology, FACMT

Rana is an Arab Board certified Emergency medicine physician and a clinical toxicologist. She was employed at Hamad Medical Corporation-Qatar as Associate Consultant until 2021. She graduated from Aden University – Republic of Yemen in 2003. She completed Arab Board Emergency Medicine certification from HMC-Qatar in 2012. She obtained membership of Royal College of emergency medicine-UK in 2014 followed by fellowship in emergency medicine (subspecialty-medical toxicology) from HMC-Qatar in 2017. She also obtained Post graduate Diploma in Toxicology from Cardiff University- UK in 2016 and Master of Science- Medical Toxicology from PGIM-Colombo-Sri Lanka in 2022.

She was an active core faculty member with Arab Board Emergency Medicine Residency program from 2013 to 2021 which is ACGME-I accredited training center and is primarily based at Hamad General hospital- Doha, Qatar. She conducted didactic lectures, workshops and clinical simulations for Emergency Medicine residents. She was in charge of the Toxicology Tract and took special interest in delivering a diversity of workshops & simulations in this subject and conducted numerous sessions to train the residents throughout her career. She was also a

clinical lecturer at Qatar University, where she taught medical students through Interactive lectures, simulations and workshops for seven consecutive years. She functioned as a founder member of Hamad Medical Corporation’s 24*7 on-Call Toxicology services in Qatar from 2014 to 2021 where she provided round the clock care to the intoxicated patients and contributed immensely in preparing a toxicology database for the organization.

She is also a member of the TAPNA (Toxicology and Poisons Network Australasia) and MENATOX (Middle East and North African Clinical Toxicology Association). She has also presented talks on several toxicology topics in numerous prestigious international conferences in various countries across the globe. She migrated to Australia in late 2021 and is now providing her expert services to WACHS (Western Australian County Health Services). She aspires to excel as an educator of Emergency medicine & Medical Toxicology and train junior medical staff worldwide.

Hong Kim, MD, MPH, FACMT

Dr. Hong Kim, MD, MPH, FACMT is an Associate Professor of Emergency Medicine and Pharmacology at the University of Maryland School of Medicine. He graduated from University of California, San Francisco School of Medicine and completed his emergency medicine residency and medical toxicology fellowship at the New York University (NYU)/Bellevue Hospital Center and NYU/New York City Poison Control Center, respectively. Dr. Kim is affiliated with Maryland Poison Center and National Capital Poison Center and leads the Medical Toxicology Consultation Service at the University of Maryland Medical Center. Aside from spending his time with his two children, he enjoys “restoring” vintage receivers and speakers, and paddling outrigger canoes on the Potomac River in Washington D.C. during his free time.

Jeffrey Lai, MD, FACMT

Jeffrey Lai, MD, is an emergency physician and medical toxicologist at UMass Chan Medical School. He completed his undergraduate studies at the University of California, Berkeley, and medical school at the University of Pittsburgh. Following emergency medicine residency and medical toxicology fellowship at UMass, he stayed on as core faculty in the emergency medicine residency and now serves as the program director of the medical toxicology fellowship. His academic interests include medical education, medications for treatment of substance use disorders, emerging drug trends, and drug-impaired driving.

Daniel Lasoff, MD, FACMT

Daniel Lasoff, MD, serves as the Director of the UC San Diego Medical Toxicology Fellowship and is an Associate Clinical Professor of Emergency Medicine at UC San Diego. As a core faculty member for the UC San Diego Emergency Medicine Residency, he also holds the position of Assistant Director at the California Poison Control System’s San Diego site. Dr. Lasoff divides his clinical time between the Emergency Departments of UC San Diego Medical Center and El Centro Regional Medical Center, a rural community hospital in Imperial County, California. Additionally, he works as a Medical Toxicologist for both UC San Diego Medical Center and San Diego’s Rady Children’s Hospital, and is the sole Medical Toxicologist at the San Diego Veterans’ Health Administration Environmental Health Clinic. Dr. Lasoff has dedicated efforts to improve care for patients with substance use disorders within the UC San Diego Health System and the broader region, focusing on increasing access to critical life saving treatments such as buprenorphine and free naloxone in the Emergency Department. Furthermore, he promotes evidence-based treatments for these serious diseases through community education.

Kevin Maskell, MD, MSc, FACMT

Dr. Kevin Maskell, MD, MSc, is an assistant professor of military and emergency medicine at the Uniformed Services University of Health Sciences.  He graduated from emergency medicine residency at Madigan Army Medical Center in 2014 and from medical toxicology fellowship at Virginia Commonwealth University in 2016.  After completing his training, Dr. Maskell returned to Madigan Army Medical Center as residency core faculty and director of medical toxicology in 2016 and in 2017 started as a consulting toxicologist for the Washington Poison Center.  In 2021 Kevin also earned board certification in addiction medicine.  Since that year, he has also been assigned by the Army as medical director and now chief of the Tactical Medicine Readiness Division at Ft. Sam Houston, Texas, where he provides critical pre-deployment trauma training for healthcare professionals scheduled to deploy into combat zones.  Dr. Maskell’s research interests include antidotal therapies, extracorporeal therapies, and envenomations. 

Dan McCabe, MD, FACMT

Dan McCabe is a Clinical Associate Professor of Emergency Medicine at the University of Iowa. He is the Director of the Division of Medical Toxicology at the University of Iowa and the Medical Director of the Iowa Poison Control Center. He completed medical school at the University of Iowa, an Emergency Medicine residency at Cook County Hospital, and a Medical Toxicology fellowship at Regions Hospital/Minnesota Poison Control System. His career focus is on improving the care of poisoned patients while decreasing unnecessary resource utilization.

Nicholas Nacca, MD, FACMT

Nicholas Nacca, MD, is Director of Medical toxicology and Associate Fellowship Director for the University of Rochester Medical Center (URMC) Medical Toxicology fellowship; Clerkship Director for the Medical Student rotation in Medical Toxicology; core faculty for the URMC emergency medicine residency; Assistant professor of Emergency Medicine.  He is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine.  He is the organizer and host of the ACMT Grand Rounds Webinar Series. 

Joshua Nogar, MD, FACMT

Dr. Nogar grew up in the High Desert of New Mexico, but has been a New Yorker for 16 years. He has been faculty in the department of Emergency Medicine and Medical Toxicology at Northwell Health/North Shore University Hospital since 2011. He has been the Medical Toxicology Fellowship director at Northwell Health since 2016, and his areas of specific interest include fellow education, metabolic uncouplers, overdose trends, and addiction medicine. He is dedicated to helping his trainees achieve their individual career goals, as well as adapting his training program to the changing scope of practice for Medical Toxicologists, as well as the needs of individual learners. Outside of work, Dr. Nogar enjoys spending time with his wife, Andrea, and their daughters, Julia and Alex. He is an avid fly-fisherman, and whiskey snob. 

Aynur Sahin, MD, PhD, FACMT

Aynur Sahin is an associate professor of Emergency Medicine and Medical Toxicology consultant at the University of Health Sciences Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye. She completed her residency in Emergency Medicine at Karadeniz Technical University (KTU)in 2012, PhD degree in toxicology at Dokuz Eylül University Department of Pharmacology in 2018, and her medical toxicology fellowship at Emory University in 2019 with mentorship and great support from Prof Ziad Kazzi. She became the first and only medical toxicologist across the country as medical toxicology is not a recognized subspecialty in Turkiye. After graduation from the fellowship program, she established the first medical toxicology consultation service and inpatient unit at KTU Department of Emergency Medicine that serves the whole Black Sea Region. She organized the MENATOX 2020 conference in Istanbul, Turkiye before COVID pandemic and was selected as a board member of MENATOX. In 2021, she led a telemedicine and educational collaboration project with Emory University Division of Medical Toxicology. In 2022 she organized the first international medical toxicology conference in Trabzon with collaboration between KTU and Emory University and more than 30 experts from all over the world have participated. She was invited to establish the first medical toxicology ICU in Istanbul by Prof. Semih Korkut who is the former general director of emergency healthcare services at the Turkish Ministry of Health and with his great support in September 2022 she established the first and only Medical Toxicology ICU where more than 1000 critically ill poisoned patient have taken care of in a year by her team. On March 11, 2024, the Turkish MoH agreed to recognize medical toxicology as a subspecialty and build a national clinical training program by their official submission 1 year ago. As of July 2024, she will lead a telemedicine and international medical toxicology training program with a collaboration Project between Basaksehir Cam and Sakura City Hospital Medical Toxicology ICU and Emory University Division of Medical Toxicology. Also, she is an international member of ACMT and contributes to WHO meetings and international medical toxicology conferences. Last but not least, she is proud to be the mother of Berat Eren Sahin who is the love of her life, and biggest fan, and had to sacrifice time with his mother during her dedicated tox journey.

Joshua Shulman, MD, FACMT

Dr. Joshua Shulman, MD is the Medical Director of the Pittsburgh Poison Center. He completed his undergraduate Summa Cum Laude at the University of Pittsburgh with a Bachelor of Arts and a Bachelor of Sciences (B.A./B.S.) in History and Neuroscience. He completed his Medical Doctorate (MD) degree at the University of Pittsburgh School of Medicine in 2012. He trained as a resident physician at UPMC Medical Education in Emergency Medicine from 2012 to 2015, and as a fellow in Medical Toxicology between 2015 and 2017. He was appointed a position of Assistant Professor of Emergency Medicine and Medical Toxicology at the University of Pittsburgh School of Medicine. He also holds an appointment as an Assistant Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. He is a diplomate of the American Board of Emergency Medicine, American Board of Medical Toxicology, and the American Board of Preventative Medicine in Addiction Medicine. He is currently practicing in UPMC Hospitals in the fields of Emergency Medicine, Medical Toxicology and Addiction Medicine.

George Sam Wang, MD, FACMT

Dr. G. Sam Wang completed his pediatric residency and pediatric emergency medicine fellowship at Children’s Hospital Colorado in Denver, followed by his Medical Toxicology Fellowship at the Rocky Mountain Poison and Drug Safety at Denver Health Hospitals. He is currently an Associate Professor of Pediatrics at Children’s Hospital Colorado in the Section of Emergency Medicine and Medical Toxicology, and on faculty at RMPDS. He is also the Associate Medical Editor for the Pediatric Telehealth Triage Guidelines at Schmitt-Thompson Clinical Content. His main academic interests include the public health impact of cannabis use and legalization, and risk mitigation strategies for the pediatric population from the opioid epidemic.

Patrick Whiteley, MD, FACMT

Patrick Whiteley, MD, is a senior partner with Kaiser Permanente in San Jose, CA.  He is a member of the KP NCAL Regional Toxicology service providing consultation services for 21 service areas and hospitals.  For his local Emergency Department he is the Pediatric Emergency Care Coordinator as well as a member of the Controlled Substance Safety Clinical Workgroup. He is board certified in Emergency Medicine and Medical Toxicology. He takes special interest in educational opportunities as a faculty member for Pediatric Fundamentals of Critical Care Simulations (PFCCS) and teaching local residents and visiting medical students.

Matthew Dernbach, MD

Matthew R. Dernbach, MD is a board-certified psychiatrist and first-year medical toxicology fellow at Emory University and the Centers for Disease Control and Prevention. He is a graduate of Yale University and the University of Rochester School of Medicine and Dentistry, and completed his residency in psychiatry at the Medical University of South Carolina. His research interests lie at the interface of mental health, addiction and medical toxicology, with an emphasis on the continuity of care for patients who present to the Emergency Department due to an overdose.

Charlotte Goldfine, MD

Charlotte Goldfine, MD is an emergency medicine physician and medical toxicologist at Brigham and Women’s Hospital (BWH). She is the course director for the Harvard-Affiliated Emergency Medicine Residency toxicology core rotation and the BWH site fellowship director for the Harvard Toxicology Fellowship. Her research is focused on medication safety, medical education, and advances in digital health technologies, novel therapeutics, and drug-delivery systems in the treatment of substance use disorders.

Jacob Lebin, MD

Jacob Lebin, MD is faculty in the Department of Emergency Medicine at the University of Colorado School of Medicine. He is a graduate of the University of Colorado at Boulder and the University of Colorado School of Medicine. Dr. Lebin completed his residency in emergency medicine at the University of Washington and his medical toxicology fellowship at the University of California, San Francisco. His clinical time is split between the University of Colorado Hospital’s emergency department and the medical toxicology consultation service associated with the Rocky Mountain Poison Center. His research interests include best practices for the management of alcohol withdrawal and the use of clinical decision support for ED-based treatment of alcohol and opioid use disorder.

Jennifer Love, MD

Jennifer Love is an assistant professor of emergency medicine at the Icahn School of Medicine at Mount Sinai. She received her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She trained in emergency medicine at the University of Pennsylvania where she also served as chief resident. Dr. Love completed a medical toxicology fellowship at Oregon Health & Science University.  She also completed the NIH T32 training program in emergency care research and a Master of Clinical Research at Icahn School of Medicine at Mount Sinai.  Her areas of interest include novel substances of misuse and mentoring women in medicine.  Her current research focuses on clinical outcomes related to xylazine-adulterated opioids.

Simon Ostrowski, MD

Simon Ostrowski is a medical toxicology fellow at the University of Pittsburgh Medical Center. He is a graduate of Boston University and the University of Massachusetts Medical School. Simon completed his residency in emergency medicine at University of Pittsburgh Medical Center where he served as chief resident, and stayed in Pittsburgh for fellowship. His academic interests include wearable biosensor use in alcohol withdrawal, medication for opioid use disorder, emergency medicine systems/operations, and the intersection of toxicology and public health. In his free time he enjoys taking walks to the nearest coffee shop with his wife, daughter, and corgi.

Michael Simpson, MD

Michael Simpson is an emergency physician and medical toxicologist at Beth Israel Deaconess Medical Center. He completed his residency at Vanderbilt University Medical Center and his medical toxicology fellowship at the Harvard Medical Toxicology Fellowship. His research interests include prediction and management of cardiovascular toxicity in acute drug overdose. Future research plans include further study of bupropion cardiotoxicity and developing strategies to appropriately identify and treat drug-induced cardiogenic shock.

C. James Watson, MD

A native of Portland, Maine, Christopher James Watson, MD (James) earned his bachelor of arts degree in political science from Davidson College in 2011 and his medical degree from the University of Chicago Pritzker School of Medicine in 2017. He completed medical training in Boston at Beth Israel Deaconess Medical Center’s Harvard Affiliated Emergency Medicine Residency (2020) and Boston Children’s Hospital’s Harvard Medical Toxicology Fellowship (2022).

Dr. Watson is board-certified in both Emergency Medicine and Medical Toxicology. In 2022, he joined Maine Medical Center, where he is core faculty for the emergency medicine residency program, practices as a medical toxicologist for the Northern New England Poison Center, and holds an appointment as Assistant Professor of Emergency Medicine at Tufts University School of Medicine. Dr. Watson is an active member of multiple national medical societies and serves on the American College of Medical Toxicology’s Clinical Practice & Position Statements Committee. Dr. Watson’s academic interests include the acute treatment of substance use disorders and resource utilization as it pertains to toxicology.